Erythema multiforme with tumour necrosis factor inhibitors: A class effect?

Annals of the Rheumatic Diseases

Volumn 67, Issue 6, 2008, Pages 899-900

  Kain, T ^a   MacGregor, D ^a   Buchanan, R R C ^a   De Jager, J P ^b   Schachna, Lionel ^a  

^a AUSTIN HEALTH   (Australia)

^b GOLD COAST UNIVERSITY HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; ETANERCEPT; HYDROCORTISONE; INFLIXIMAB; PROMETHAZINE;

ADULT; ANKYLOSING SPONDYLITIS; ANTIBODY TITER; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPIDERMOLYSIS; ERYTHEMA MULTIFORME; HUMAN; LETTER; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL; PUNCH BIOPSY;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ERYTHEMA MULTIFORME; HUMANS; MALE; MIDDLE AGED; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 45149102457     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2007.078857     Document Type: Letter

References (7)

1. Soliotis F, Glover M, Jawad AS. Severe skin reaction after leflunomide and etanercept in a patient with rheumatoid arthritis. Ann Rheum Dis 2002;61:850-1.
2. Flendrie M, Vissers WH, Creemers MC, de Jong EM, van de Kerkhof PC, van Riel PL. Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study. Arthritis Res Ther 2005;7:R666-76.
3. Vergara G, Silvestre JF, Betlloch I, Vela P, Albares MP, Pascual JC. Cutaneous drug eruption to infliximab: report of 4 cases with an interface dermatitis pattern. Arch Dermatol 2002;138:1258-9.
4. Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schroder W, Roujeau JC. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol 2002;138:1019-24.
5. Rowell NR, Beck NJ, Anderson JR. Lupus erythematosus and erythema multiforme-like lesions. Arch Dermatol 1963;88:176-80.
6. Comby E, Tanaff P, Mariotte D, et al. Evolution of antinuclear antibodies and clinical patterns in patients with active rheumatoid arthritis with longterm infliximab therapy. J Rheumatol 2006;33:24-30.
7. Caproni M, Torchia D, Schincaglia E, et al. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis. Br J Dermatol 2006;155:722-8.